CapnoPharm

CapnoPharm is a specialized medical technology and biotechnology company focused on the treatment of peritoneal surface malignancies. The company pioneered the Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) procedure, which utilizes its proprietary CapnoPen device to deliver chemotherapy as a pressurized aerosol directly into the abdominal cavity. This innovative drug delivery method allows for deeper tissue penetration and more uniform distribution of therapeutic agents compared to traditional liquid washes or systemic administration. CapnoPharm's technology is primarily used to treat advanced peritoneal metastases originating from gastric, ovarian, and colorectal cancers. By localizing treatment, the company aims to improve patient survival and quality of life while significantly reducing the systemic toxicity associated with conventional chemotherapy.